Immediate Impact
55 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
Works of Chaoxun Wang being referenced
An Overview of Similarities and Differences in Metabolic Actions and Effects of Central Nervous System Between Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium Glucose Co-Transporter-2 Inhibitors (SGLT-2is)
2021
<p>Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice</p>
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chaoxun Wang | 231 | 123 | 75 | 77 | 15 | 449 | |
| Makoto Tsugita | 156 | 102 | 64 | 31 | 18 | 394 | |
| D. Travia | 155 | 83 | 84 | 75 | 17 | 428 | |
| Christos Kalofoutis | 170 | 131 | 76 | 36 | 17 | 491 | |
| C. Crepaldi | 199 | 64 | 109 | 38 | 19 | 463 | |
| Rieko Hayaishi-Okano | 245 | 63 | 52 | 36 | 8 | 490 | |
| Silvia Magno | 148 | 163 | 147 | 31 | 28 | 505 | |
| Gerd Albuszies | 127 | 94 | 80 | 29 | 15 | 505 | |
| T Matsuoka | 120 | 116 | 117 | 58 | 15 | 399 | |
| Chen‐Fee Lim | 342 | 134 | 30 | 25 | 17 | 484 | |
| Xiaoming Tao | 156 | 130 | 58 | 60 | 22 | 466 |
All Works
Login with ORCID to disown or claim papers
Loading papers...